RPG Life Sciences
Ticker > Company >

RPG Life Sciences share price

RPG Life Sciences Ltd.

NSE: RPGLIFE BSE: 532983 SECTOR: Pharmaceuticals & Drugs  49k   223   22

2253.05
-97.80 (-4.16%)
BSE: 12 Nov 04:01 PM

Price Summary

Today's High

₹ 2359.45

Today's Low

₹ 2250

52 Week High

₹ 2976.7

52 Week Low

₹ 1290.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3726.32 Cr.

Enterprise Value

₹ 3689.85 Cr.

No. of Shares

1.65 Cr.

P/E

52.74

P/B

9.82

Face Value

₹ 8

Div. Yield

0.71 %

Book Value (TTM)

₹  229.39

CASH

₹ 36.47 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

72.81 %

EPS (TTM)

₹  42.72

Sales Growth

13.5%

ROE

25.69 %

ROCE

34.96%

Profit Growth

29.6 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of RPG Life Sciences Ltd.

Lomotil Lomofen Naprosyn Azoran Aldactone and Serenace Minmin Tonic Romilast Tricaine Sildura

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.5%
3 Year14.36%
5 Year12.01%

Profit Growth

1 Year29.6%
3 Year29.89%
5 Year51.98%

ROE%

1 Year25.69%
3 Year23.84%
5 Year21.81%

ROCE %

1 Year34.96%
3 Year33.11%
5 Year29.39%

Debt/Equity

0

Price to Cash Flow

39.49

Interest Cover Ratio

82.8333

CFO/PAT (5 Yr. Avg.)

1.29943072627724

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 72.81 0.00
Jun 2024 72.81 0.00
Mar 2024 72.81 0.00
Dec 2023 72.81 0.00
Sep 2023 72.81 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 29.8914280870675% for the Past 3 years.
  • The company has significantly decreased its debt by 0.01 Cr.
  • Company has been maintaining healthy ROE of 23.8352655739556% over the past 3 years.
  • Company has been maintaining healthy ROCE of 33.1112574526717% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 82.8333.
  • The company has an efficient Cash Conversion Cycle of -64.9162 days.
  • Company has a healthy liquidity position with current ratio of 2.2762.
  • The company has a good cash flow management; CFO/PAT stands at 1.29943072627724.
  • The company has a high promoter holding of 72.81%.

 Limitations

  • The company has shown a poor revenue growth of 14.3626534908383% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 153.58 153.7 126.99 165.42 172.21
Total Expenditure 116.29 115.8 106.27 126.35 126.28
Operating Profit 37.29 37.9 20.72 39.07 45.93
Other Income 1.83 1.92 1.65 2.37 1.94
Interest 0.1 0.14 0.14 0.15 0.17
Depreciation 4.23 4.14 4.49 5.29 5.31
Exceptional Items 0 0 0 0 -27.3
Profit Before Tax 34.79 35.54 17.74 36 15.09
Tax 8.93 9.08 4.5 9.24 10.89
Profit After Tax 25.86 26.46 13.24 26.76 4.2
Adjusted EPS (Rs) 15.64 16 8.01 16.18 2.54

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 375.57 389.14 440.16 512.81 582.05
Total Expenditure 315.67 318.37 353 409.28 452.91
Operating Profit 59.9 70.77 87.16 103.53 129.14
Other Income 0.99 1.07 3.08 4.8 7.21
Interest 2.76 1.79 1.41 1.15 1.44
Depreciation 16.36 16.47 15.66 15.5 17.07
Exceptional Items -5.32 0 0 0 0
Profit Before Tax 36.45 53.58 73.17 91.68 117.84
Tax 7.44 13.58 21.69 24.04 30.18
Net Profit 29.01 40 51.48 67.64 87.66
Adjusted EPS (Rs.) 17.54 24.19 31.13 40.9 53.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 13.23 13.23 13.23 13.23 13.23
Total Reserves 163.34 203.22 242.54 294.37 361.62
Borrowings 1.52 0.74 0.3 0 0
Other N/C liabilities 7.23 6.45 8.43 8.97 6.48
Current liabilities 82.59 79.69 80.11 102.78 130.96
Total Liabilities 267.91 303.33 344.61 419.35 512.29
Assets
Net Block 122.89 113.3 103.71 124.26 113.53
Capital WIP 7.28 9.44 25.45 15.03 84.78
Intangible WIP 2.7 2.33 5.61 10.41 11.53
Investments 0 0 0 0 1.01
Loans & Advances 9.26 2.41 2.93 5.6 3.35
Other N/C Assets 0 0 0 0 0
Current Assets 125.78 175.85 206.91 264.05 298.09
Total Assets 267.91 303.33 344.61 419.35 512.29
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 36.45 53.58 73.17 91.68 117.84
Adjustment 22.52 16.55 13.54 13.31 12.92
Changes in Assets & Liabilities -2.37 -3.53 -3.11 11.06 -7.09
Tax Paid -6.43 -8.33 -18.85 -25.23 -29.31
Operating Cash Flow 50.17 58.27 64.75 90.82 94.36
Investing Cash Flow -10.7 -7.96 -34.66 -105.81 -79.15
Financing Cash Flow -39.3 -10.49 -13.51 -17.12 -20.31
Net Cash Flow 0.17 39.82 16.58 -32.11 -5.1

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 72.81 72.81 72.81 72.81 72.81
carniwal investments ltd 0.04 0.04 0.04 0.04 0.04
ektara enterprises llp 15.57 15.57 15.57 15.57 15.57
harsh vardhan goenka 0.16 0.16 0.16 0.16 0.16
mala goenka 0.05 0.05 0.05 0.05 0.05
nucleus life trust (mr. h... 53.80 53.80 53.80 53.80 53.80
stel holdings limited 3.18 3.18 3.18 3.18 3.18
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 27.19 27.19 27.19 27.19 27.19
authum investment and inf... 2.02 2.02 2.02 2.02 2.02
investor education and pr... - - 1.03 - 1.03
llp 0.07 0.08 0.08 0.08 0.08
mirae asset multicap fund... - 1.08 1.42 1.58 1.58
investor education and pr... 1.03 - - 1.03 -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Rpg Life Sciences informs about investor presentation 8 Nov, 4:42 PM RPG Life Sciences - Quaterly Results 7 Nov, 6:06 PM RPG Life Sciences - Quaterly Results 7 Nov, 6:06 PM Rpg Life Sciences informs about loss of share certificate 26 Oct, 2:51 PM Rpg Life Sciences informs about analyst meet 8 Aug, 2:36 PM Rpg Life Sciences informs about press release 20 Jul, 11:50 AM RPG Life Sciences - Quaterly Results 19 Jul, 5:57 PM RPG Life Sciences - Quaterly Results 19 Jul, 5:57 PM RPG Life Sciences - Quaterly Results 19 Jul, 5:57 PM RPG Life Sciences - Quaterly Results 30 Apr, 7:51 PM RPG Life Sciences - Quaterly Results 30 Apr, 7:51 PM RPG Life Sciences signs Share Subscription, Shareholders' agreement with Sunpound 12 Mar, 5:40 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:49 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:49 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:49 PM RPG Life Sciences informs about details of loss of certificate 20 Dec, 4:36 PM RPG Life Sciences informs about investor presentation 19 Oct, 5:09 PM RPG Life Sciences to execute power delivery agreement with Sunpound 19 Oct, 11:51 AM RPG Life Sciences - Quaterly Results 18 Oct, 6:23 PM RPG Life Sciences - Quaterly Results 18 Oct, 6:23 PM Rpg Life Sciences informs about loss of share certificate 16 Oct, 4:51 PM RPG Life Sciences informs about certificate 11 Oct, 3:53 PM Rpg Life Sciences informs about press release 29 Jul, 2:59 PM RPG Life Sciences - Quaterly Results 28 Jul, 5:50 PM RPG Life Sciences - Quaterly Results 28 Jul, 5:50 PM RPG Life Sciences - Quaterly Results 28 Jul, 5:50 PM RPG Life Sciences informs about transcript of earnings call 8 May, 11:18 AM RPG Life Sciences - Quaterly Results 28 Apr, 6:54 PM RPG Life Sciences - Quaterly Results 28 Apr, 6:54 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:33 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:33 PM RPG Life Sciences - Quaterly Results 1 Feb, 5:33 PM RPG Life Sciences - Quaterly Results 17 Oct, 6:43 PM RPG Life Sciences - Quaterly Results 17 Oct, 6:43 PM RPG Life Sciences - Quaterly Results 17 Oct, 6:43 PM RPG Life Sciences - Quaterly Results 2 Aug, 6:17 PM RPG Life Sciences - Quaterly Results 2 Aug, 6:17 PM RPG Life Sciences - Quaterly Results 29 Apr, 6:21 PM RPG Life Sciences informs about newspaper publications 27 Jan, 4:52 PM RPG Life Sciences informs about loss of share certificate 24 Nov, 4:33 PM RPG Life Sciences informs about loss of share certificate 18 Oct, 12:21 PM RPG Life Sciences informs about loss of share certificate 11 Oct, 10:59 AM RPG Life Sciences informs about newspaper publication 10 Aug, 4:37 PM RPG Life Sciences informs about details of loss of share certificate 31 Jul, 1:17 PM RPG Life Sciences informs about investor presentation 26 Jun, 12:51 PM RPG Life Sciences informs loss of share certificate 27 May, 3:49 PM RPG Life Sciences reply to clarification sought by exchanges for increase in volume 22 Apr, 3:55 PM RPG Life Sciences informs about newspaper publications 27 Jan, 3:22 PM RPG Life Sciences, Seniority launches ‘SafeSeniors’ risk monitoring tool for senior citizens 7 Apr, 12:52 PM

RPG Life Sciences Stock Price Analysis and Quick Research Report. Is RPG Life Sciences an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into RPG Life Sciences and its performance over the period of time. RPG Life Sciences stock price today is Rs 2344.1.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. RPG Life Sciences cash from the operating activity was Rs 94.36 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. RPG Life Sciences has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In RPG Life Sciences , the EPS growth was 29.5978 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, RPG Life Sciences has OPM of 22.1870973284082 % which is a good sign for profitability.
     
  • ROE: RPG Life Sciences have a healthy ROE of 25.6898 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of RPG Life Sciences is Rs 2344.1. One can use valuation calculators of ticker to know if RPG Life Sciences share price is undervalued or overvalued.
Last Updated on:
Brief about RPG Life Sciences

RPG Life Sciences Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

RPG Life Sciences Ltd. is a leading pharmaceutical company specializing in the manufacturing and marketing of quality pharmaceutical products. With a rich history spanning several decades, RPG Life Sciences has become a trusted name in the healthcare industry. The company is committed to delivering innovative and affordable medicines to improve the quality of life for patients across the globe.

RPG Life Sciences Ltd. Share Price

Stay up-to-date with RPG Life Sciences Ltd.'s share price and track its performance in the stock market. Our website provides real-time and historical share price data, enabling investors to make informed decisions. Our pre-built screening tools allow you to analyze RPG Life Sciences Ltd.'s share price, helping you identify trends and patterns.

RPG Life Sciences Ltd. Balance Sheet

The balance sheet is an essential financial statement that provides a snapshot of RPG Life Sciences Ltd.'s financial position at a given point in time. By examining the company's assets, liabilities, and equity, investors can assess its financial stability and solvency. Our website offers access to RPG Life Sciences Ltd.'s balance sheet as a downloadable document. Take advantage of our premium features, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, to perform a thorough evaluation of the balance sheet.

RPG Life Sciences Ltd. Annual Report

The annual report is a comprehensive document that provides insights into RPG Life Sciences Ltd.'s performance, strategies, and future prospects. It includes information on the company's financials, business operations, milestones, and achievements. At our website, you can easily download RPG Life Sciences Ltd.'s annual report, enabling you to dive deeper into the company's performance and outlook.

RPG Life Sciences Ltd. Dividend

RPG Life Sciences Ltd. is committed to creating value for its shareholders. One way the company rewards its shareholders is through dividends. Dividends provide investors with a portion of the company's profits. Stay updated on RPG Life Sciences Ltd.'s dividend history and declared dividends on our website. Analyze the company's dividend payment pattern and evaluate its potential as an income-generating investment.

RPG Life Sciences Ltd. Quarterly Result

Track RPG Life Sciences Ltd.'s quarterly performance and stay informed about the company's financial results. Our website offers access to RPG Life Sciences Ltd.'s quarterly reports as downloadable documents. Combine the quarterly results with our premium features, such as DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, to gain a comprehensive understanding of the company's financials and performance trends.

RPG Life Sciences Ltd. Stock Price

Stay connected to the latest stock price movements of RPG Life Sciences Ltd. Our website provides real-time updates on the stock's performance, helping you make informed investment decisions. Utilize RPG Life Sciences Ltd.'s stock price chart to identify price trends and patterns. Our pre-built screening tools offer additional insights into RPG Life Sciences Ltd.'s stock price, empowering you to conduct a thorough analysis.

RPG Life Sciences Ltd. News

Keep yourself updated with the latest news and developments related to RPG Life Sciences Ltd. Our website provides a dedicated news section, aggregating news articles and press releases relevant to the company. Stay informed about market trends, regulatory changes, product launches, partnerships, and more. Access to reliable and relevant news can help you make informed investment decisions.

RPG Life Sciences Ltd. Concall Transcripts

Eager to gain insights directly from RPG Life Sciences Ltd.'s management team? Our website offers downloadable concall transcripts, allowing you to access firsthand information shared during the company's conference calls. By reviewing the concall transcripts, investors can gain a deeper understanding of RPG Life Sciences Ltd.'s strategies, performance updates, and future prospects.

RPG Life Sciences Ltd. Investor Presentations

Our website provides downloadable investor presentations by RPG Life Sciences Ltd. These presentations offer valuable insights into the company's business model, growth strategies, financial performance, and objectives. The presentations are an excellent resource for investors looking to understand RPG Life Sciences Ltd.'s value proposition and investment potential.

RPG Life Sciences Ltd. Promoters

The promoters of RPG Life Sciences Ltd. play a crucial role in the company's success. Our website provides detailed information about the promoters and their contributions to the company's growth. Understanding the promoters' background, experience, and vision can provide investors with valuable insights and help them evaluate the company's long-term prospects.

RPG Life Sciences Ltd. Shareholders

Explore RPG Life Sciences Ltd.'s shareholder base and understand the company's ownership structure. Our website offers insights into the major shareholders of RPG Life Sciences Ltd., providing information about institutional investors, mutual funds, and individual investors holding significant positions in the company. Understanding the shareholder base can help investors assess the confidence and support the company enjoys from the market.

By providing comprehensive stock analysis resources like company profiles, share prices, balance sheets, annual reports, dividends, quarterly results, stock prices, price charts, news, concall transcripts, investor presentations, promoters, and shareholders, our website strives to empower long-term stock investors looking for in-depth analysis. Additionally, our premium features, such as fair value calculation tools like DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, offer advanced insights to support your investment decisions. Access these resources and tools on our website to gain a comprehensive understanding of RPG Life Sciences Ltd.'s stock and make informed investment choices.

Read More
X